A cellular automaton for the factor of safety field in landslides modeling

Landslide inventories show that the statistical distribution of the area of recorded events is well described by a power law over a range of decades. To understand these distributions, we consider a cellular automaton to model a time and position dependent factor of safety. The model is able to reproduce the complex structure of landslide distribution, as experimentally reported. In particular, we investigate the role of the rate of change of the system dynamical variables, induced by an external drive, on landslide modeling and its implications on hazard assessment. As the rate is increased, the model has a crossover from a critical regime with power-laws to non power-law behaviors. We suggest that the detection of patterns of correlated domains in monitored regions can be crucial to identify the response of the system to perturbations, i.e., for hazard assessment.Comment: 4 pages, 3 figure

Treatment of end-of-life concrete in an innovative heating-air classification system for circular cement-based products

A stronger commitment towards Green Building and circular economy, in response to environmental concerns and economic trends, is evident in modern industrial cement and concrete production processes. The critical demand for an overall reduction in the environmental impact of the construction sector can be met through the consumption of high-grade supplementary raw materials. Advanced solutions are under development in current research activities that will be capable of up-cycling larger quantities of valuable raw materials from the fine fractions of End-of-Life (EoL) concrete waste. New technology, in particular the Heating-Air classification System (HAS), simultaneously applies a combination of heating and separation processes within a fluidized bed-like chamber under controlled temperatures (±600 °C) and treatment times (25–40 s). In that process, moisture and contaminants are removed from the EoL fine concrete aggregates (0–4 mm), yielding improved fine fractions, and ultrafine recycled concrete particles (<0.125 mm), consisting mainly of hydrated cement, thereby adding value to finer EoL concrete fractions. In this study, two types of ultrafine recycled concrete (either siliceous or limestone EoL concrete waste) are treated in a pilot HAS technology for their conversion into Supplementary Cementitious Material (SCM). The physico-chemical effect of the ultrafine recycled concrete particles and their potential use as SCM in new cement-based products is assessed by employing substitutions of up to 10% of the conventional binder. The environmental viability of their use as SCM is then evaluated in a Life Cycle Assessment (LCA). The results demonstrated accelerated hydration kinetics of the mortars that incorporated these SCMs at early ages and higher mechanical strengths at all curing ages. Optimal substitutions were established at 5%. The results suggested that the overall environmental impact could be reduced by up to 5% when employing the ultrafine recycled concrete particles as SCM in circular cement-based products, reducing greenhouse gas emissions by as much as 41 kg CO2 eq./ton of cement (i.e. 80 million tons CO2 eq./year). Finally, the environmental impacts were reduced even further by running the HAS on biofuel rather than fossil fuel.The authors of the present paper, prepared in the framework ofthe Project VEEP "Cost-Effective Recycling of C&DW in High AddedValue Energy Efficient Prefabricated Concrete Components forMassive Retrofitting of our Built Environment", wish to acknowl-edge the European Commission for its support. This project hasreceived funding from the European Union’s Horizon 2020 researchand innovation programme under grant agreement No 723582.This paper reflects only the author’s view and the European Com-mission is not responsible for any use that may be made of theinformation it contains.The authors are also grateful to the Spanish Ministry of Science,Innovation and Universities (MICIU) and the European RegionalDevelopment Fund (FEDER) for funding this line of research(RTI2018-097074-B-C21)

The ACEGES 1.0 Documentation: Simulated Scenarios of Conventional Oil Production

he ACEGES (Agent-based Computational Economics of the Global Energy System) 1.0 model is an agent-based model of conventional oil production for 93 countries. The model accounts for four key uncertainties, namely Estimated Ultimate Recovery (EUR), estimated growth in oil demand, estimated growth in oil production and assumed peak/decline point. This documentation provides an overview of the ACEGES model capabilities and an example of how it can be used for long-term (discrete and continuous) scenarios of conventional oil production

The ACEGES 1.0 Documentation: Simulated Scenarios of Conventional Oil Production

he ACEGES (Agent-based Computational Economics of the Global Energy System) 1.0 model is an agent-based model of conventional oil production for 93 countries. The model accounts for four key uncertainties, namely Estimated Ultimate Recovery (EUR), estimated growth in oil demand, estimated growth in oil production and assumed peak/decline point. This documentation provides an overview of the ACEGES model capabilities and an example of how it can be used for long-term (discrete and continuous) scenarios of conventional oil production

LPS, Oleuropein and Blueberry extracts affect the survival, morphology and Phosphoinositide signalling in stimulated human endothelial cells

Endothelial cells (EC) act as leading actors in angiogenesis. Understanding the complex network of signal transduction pathways which regulate angiogenesis might offer insights in the regulation of normal and pathological events, including tumours, vascular, inflammatory and immune diseases. The effects of olive oil and of Blueberry extracts upon the phosphoinositide (PI)-specific phospholipase C (PLC) enzymes were evaluated both in quiescent and inflammatory stimulated human umbilical vein EC (HUVEC) using molecular biology (multiliquid bioanalysis) and immunofluorescence techniques. Oleuropein significantly increased the number of surviving HUVEC compared to untreated controls, suggesting that it favours the survival and proliferation of EC. Our results suggest that Oleuropein might be useful to induce EC proliferation, an important event during angiogenesis, with special regard to wound healing. Blueberry extracts increased the number of surviving HUVEC, although the comparison to untreated controls did not result statistically significant. Lipopolysaccharide (LPS) administration significantly reduced the number of live HUVEC. LPS can also modify the expression of selected PLC genes. Adding Blueberry extracts to LPS treated HUVEC cultures did not significantly modify the variations of PLC expression induced by LPS. Oleuropein increased or reduced the expression of PLC genes, and statistically significant results were identified for selected PLC isoforms. Oleuropein also modified the effects of LPS upon PLC genes\u2019 expression. Thus, our results corroborate the hypothesis that Oleuropein owns anti-inflammatory activity. The intracellular localization of PLC enzymes was modified by the different treatments we used. Podosome-like structures were observed in differently LPS treated HUVEC

Presence of Candida zemplinina in Sicilian Musts and Selection of a Strain for Wine Mixed Fermentations

The purpose of this work was to investigate the presence of C. zemplinina yeasts in Sicilian musts andgrapes and to identify strains of oenological interest. We report on the taxonomical reclassificationof Candida yeast isolates from Sicilian musts and on the selection of one strain of oenological interest(Cz3), based on mixed micro-fermentation experiments in sterile Nero d’Avola musts. Our results showthat Candida zemplinina is abundant in Sicilian grapes and musts, and that the Cz3 strain is suitablefor Candida zemplinina/Saccharomyces cerevisiae mixed fermentations. The higher glycerol content andthe lower ethanol level stood out as the most promising features of the wines obtained upon sequentialinoculation of the Cz3 and (S. cerevisiae) NDA21 yeast starters. We therefore have isolated a Sicilian Czstrain endowed with very promising features for the future development of mixed fermentation protocols

Remote device access in the new accelerator controls middleware

This paper presents the Remote Device Access (RDA) package developed at CERN in the framework of the joint PS/SL Controls Middleware project. The package design reflects the Accelerator Device Model in which devices, named entities in the control system, can be controlled via properties. RDA implements this model in a distributed environment with devices residing in servers that can run anywhere in the controls network. It provides a location-independent and reliable access to the devices from control programs. By invoking the device access methods, clients can read, write and subscribe to device property values. We describe the architecture and design of RDA its API, and CORBA-based implementations in Java and C++. First applications of RDA in the CERN accelerator control systems are described as well

Primary Cardiac Angiosarcoma: A Fatal Disease

A 42-year-old man with a cardiac tamponade underwent an urgent pericardiotomy that showed tumoral tissue, covering the surface of the right atrium. The tumor was then partially excised, and the histological examination revealed the presence of a moderately-differentiated angiosarcoma. The patient was then referred to the oncology unit and scheduled for a chemotherapy schedule including Epirubicin (60 mg/m2, on days 1 and 2) plus Ifosfamide (2000 mg/m2, on days 1 to 3) and Uromitexan (2000 mg/m2 at hours 0, 4, 8 after IFO). All drugs were administered every three weeks. After two cycles, a restaging work-up revealed a partial remission. The treatment was continued for another two cycles. A new evaluation by cardiac MRI evidenced a local and distant (lung) progression of disease. The patient died after three months. This paper confirms that cardiac angiosarcoma is a fatal disease, and the prognosis is usually 6–11 months from time of diagnosis